Publications

  1. Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 Nov 1; 116 (11):2296-2299
    View PubMed
  2. Sinicrope FA, Viggiano TR, Buttar NS, Song LMWK, Schroeder KW, Kraichely RE, Larson MV, Sedlack RE, Kisiel JB, Gostout CJ, Kalaiger AM, Patai AV, Della'Zanna G, Umar A, Limburg PJ, Meyers JP, Foster NR, Yang CS, Sontag S. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia. Cancer Prev Res (Phila). 2021 May; 14 (5):573-580 Epub 2021 Mar 01
    View PubMed
  3. Coelho-Prabhu N, Bruining DH, Faubion WA, Kane SV, Kisiel JB, Papadakis KA, Pardi DS, Raffals LE, Schroeder KW, Tremaine WJ, Fruth K, Harmsen WS, Loftus EV. A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy. Inflamm Bowel Dis. 2021 Apr 15; 27 (5):594-602
    View PubMed
  4. Sinicrope FA, Velamala PR, Song LMWK, Viggiano TR, Bruining DH, Rajan E, Gostout CJ, Kraichely RE, Buttar NS, Schroeder KW, Kisiel JB, Larson MV, Sweetser SR, Sedlack RR, Sinicrope SN, Richmond E, Umar A, Della'Zanna G, Noaeill JS, Meyers JP, Foster NR. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms. Cancer Prev Res (Phila). 2019 Nov; 12 (11):821-830 Epub 2019 Sept 04
    View PubMed
  5. Shivashankar R, Edakkanambeth Varayil J, Scott Harmsen W, Faubion WA, Wong Kee Song LM, Bruining DH, Schroeder KW, Kisiel J, Loftus EV Jr, Coelho Prabhu N. Outcomes of Endoscopic Therapy for Luminal Strictures in Crohn's Disease. Inflamm Bowel Dis. 2018 Jun 8; 24 (7):1575-1581
    View PubMed
  6. Deepak P, Hanson GJ, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Wong Kee Song LM, Harmsen WS, Loftus EV Jr, Bruining DH. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointest Endosc. 2016 May; 83: (5)1005-12.
    View PubMed
  7. Flanagan EP, Rabinstein AA, Kumar N, Schroeder K, Kantarci OH. Fulminant cerebellitis with radiological recurrence in an adult patient with Crohn's disease. J Neurol Sci. 2014 Jan 15; 336: (1-2)247-50.
    View PubMed
  8. Kane SV, Neis B, Becker BD, Bruining D, Faubion WA, Kisiel J, Loftus EV Jr, Pardi D, Raffals L, Schroeder K, Tremaine WJ. Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease. Aliment Pharmacol Ther 2013 Dec; 38 (11-12):1412
    View PubMed
  9. Samuel S, Bruining DH, Loftus EV Jr, Thia KT, Schroeder KW, Tremaine WJ, Faubion WA, Kane SV, Pardi DS, de Groen PC, Harmsen WS, Zinsmeister AR, Sandborn WJ. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol. 2013 Jan; 11 (1):49-54.e1 Epub 2012 Aug 16
    View PubMed
  10. Bruining DH, Siddiki HA, Fletcher JG, Sandborn WJ, Fidler JL, Huprich JE, Mandrekar JN, Harmsen WS, Evans PE, Faubion WA, Hanson KA, Ingle SB, Pardi DS, Schroeder KW, Tremaine WJ, Loftus EV Jr. Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence. Inflamm Bowel Dis. 2012 Feb; 18 (2):219-25 Epub 2011 Feb 17
    View PubMed
  11. Thia KT, Loftus EV Jr, Pardi DS, Kane SV, Faubion WA, Tremaine WJ, Schroeder KW, Harmsen SW, Zinsmeister AR, Sandborn WJ. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis. 2011 Jun; 17 (6):1257-64 Epub 2010 Sept 27
    View PubMed
  12. Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, Tremaine WJ, Egan LJ, Faubion WA, Schroeder KW, Pardi DS, Hanson KA, Jewell DA, Barlow JM, Fidler JL, Huprich JE, Johnson CD, Harmsen WS, Zinsmeister AR, Sandborn WJ. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008 Aug; 68: (2)255-66.
    View PubMed
  13. Schroeder KW. Is mesalamine safe? Gastroenterol Hepatol (N Y). 2007 Nov; 3 (11):878-9
    View PubMed
  14. Toruner M, Harewood GC, Loftus EV Jr, Sandborn WJ, Tremaine WJ, Faubion WA, Schroeder KW, Egan LJ. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis. 2005 May; 11 (5):428-34
    View PubMed
  15. Schroeder KW. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Scand J Gastroenterol Suppl. 2002; (236):42-7
    View PubMed
  16. Scolapio JS, Gostout CJ, Schroeder KW, Mahoney DW, Lindor KD. Dysphagia without endoscopically evident disease: to dilate or not? Am J Gastroenterol. 2001 Feb; 96 (2):327-30
    View PubMed
  17. Schroeder KW. Quality Assurance in Gastrointestinal Endoscopy. Gastrointestinal Endoscopy Clinics of North America. 1995; 3:571-80.
  18. Tremaine WJ, Schroeder KW, Harrison JM, Zinsmeister AR. A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis. J Clin Gastroenterol. 1994 Dec; 19 (4):278-82
    View PubMed
  19. Sandborn WJ, Tremaine WJ, Schroeder KW, Batts KP, Lawson GM, Steiner BL, Harrison JM, Zinsmeister AR. A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology. 1994 Jun; 106 (6):1429-35
    View PubMed
  20. Sandborn WJ, Tremaine WJ, Schroeder KW, Steiner BL, Batts KP, Lawson GM. Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis. Am J Gastroenterol. 1993 May; 88(5):640-5.
    View PubMed
  21. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, Spencer MP, Zinsmeister AR. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum. 1992 Oct; 35 (10):950-6
    View PubMed
  22. Reinoso MA, Schroeder KW, Pisani RJ. Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest. 1992 May; 101 (5):1469-71
    View PubMed
  23. Gostout CJ, Wang KK, Ahlquist DA, Clain JE, Hughes RW, Larson MV, Petersen BT, Schroeder KW, Tremaine WJ, Viggiano TR. Acute gastrointestinal bleeding. Experience of a specialized management team. J Clin Gastroenterol. 1992 Apr; 14 (3):260-7
    View PubMed
  24. Yamamoto H, Hughes RW Jr, Schroeder KW, Viggiano TR, DiMagno EP. Treatment of benign esophageal stricture by Eder-Puestow or balloon dilators: a comparison between randomized and prospective nonrandomized trials. Mayo Clin Proc. 1992 Mar; 67 (3):228-36
    View PubMed
  25. Chapman NJ, Brown ML, Brown ML, Phillips SF, Tremaine WJ, Schroeder KW, Dewanjee MK, Zinsmeister AR. Distribution of mesalamine enemas in patients with active distal ulcerative colitis. Mayo Clin Proc. 1992 Mar; 67 (3):245-8
    View PubMed
  26. Gostout CJ, Schroeder KW, Burton DD. Small bowel enteroscopy: an early experience in gastrointestinal bleeding of unknown origin. Gastrointest Endosc. 1991 Jan-Feb; 37 (1):5-8
    View PubMed
  27. Schroeder KW. Office Endoscopy. Overholt BF Chobanian SJ; Baltimore, Williams and Wilkins. Mayo Clin Proc. 1990; 65:1163.
  28. Schroeder KW, Tremaine WJ, Ilstrup DM. Oral mesalamine for active ulcerative colitis: initial clinical improvement predicts long-term benefit. Scand J Gastroenterol. 1989; 24(Suppl 158):142-3.
    View PubMed
  29. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987 Dec 24; 317(26):1625-9.
    View PubMed
  30. Jain NK, Larson DE, Larson DE, Schroeder KW, Burton DD, Cannon KP, Thompson RL, DiMagno EP. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987 Dec; 107 (6):824-8
    View PubMed
  31. Wang KK, Perrault J, Carpenter HA, Schroeder KW, Tremaine WJ. Collagenous colitis: a clinicopathologic correlation. Mayo Clin Proc. 1987 Aug; 62(8):665-71.
    View PubMed
  32. Larson DE, Burton DD, Schroeder KW, DiMagno EP. Percutaneous endoscopic gastrostomy. Indications, success, complications, and mortality in 314 consecutive patients. Gastroenterology. 1987 Jul; 93(1):48-52.
    View PubMed
  33. Hooyman JR, MacCarty RL, Carpenter HA, Schroeder KW, Carlson HC. Radiographic appearance of mucosal dysplasia associated with ulcerative colitis. AJR Am J Roentgenol. 1987 Jul; 149(1):47-51.
    View PubMed
  34. Schroeder KW. Surgical Gastroenterology. TV Taylor Blackwell Scientific Publications Oxford, Annals of Internal Medicine 19871, 18. 1987; 106:0.
  35. Wang KK, Bowyer BA, Fleming CR, Schroeder KW. Pulmonary infiltrates and eosinophilia associated with sulfasalazine. Mayo Clin Proc. 1984 May; 59(5):343-6.
    View PubMed
  36. Schroeder KW. Flexible fiberoptic endoscopy in the upper gastrointestinal tract. A primer for the non-endoscopist. Practical Gastroenterology. 1984; VIII:21-35.
  37. Persellin ST, Griffing WL, Michet CJ, Schroeder KW, Luthra HS. Polymyositis associated with jejunoileal bypass. J Rheumatol. 1983 Aug; 10(4):637-9.
    View PubMed
  38. Larson DE, Fleming CR, Ott BJ, Schroeder KW. Percutaneous endoscopic gastrostomy. Simplified access for enteral nutrition. Mayo Clin Proc. 1983 Feb; 58(2):103-7.
    View PubMed
  39. Schroeder KW. Cancer surveillance in patients with chronic ulcerative colitis. Mayo Clin Proc. 1981 May; 56:336-337.
  40. Schroeder KW. Frontiers of Gastrointestinal Research. The Stomach, Volume 6. Van der Reis, L (ed), Karger, S, Basel, 1980. Digestive Diseases and Sciences. 1981; 26(9):862.
  41. Spring SB, Schroeder KW, Nisonoff A. Quantitative investigations of idiotypic antibodies. V. Factors affecting the persisence and replacement of clones of antibody producing cells. J Exp Med. 1971; 134:765-85.
    View PubMed